AMPCO PITTSBURGH CORP - Quarter Report: 2019 March (Form 10-Q)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2019
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-898
AMPCO-PITTSBURGH CORPORATION
|
|
Pennsylvania |
25-1117717 |
(State of Incorporation) |
(I.R.S. Employer Identification No.) |
726 Bell Avenue, Suite 301
Carnegie, Pennsylvania 15106
(Address of principal executive offices)
(412) 456-4400
(Registrant’s telephone number)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
Emerging growth company |
☐ |
|
|
|
|
|
|
Non-accelerated filer |
☐ |
Smaller reporting company |
☒ |
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, $1 par value |
AP |
New York Stock Exchange |
On May 3, 2019, 12,513,269 common shares were outstanding.
INDEX
|
|
|
|
Page No. |
|||
Part I – |
|
Financial Information: |
|
|
|||
|
|
|
|
|
|
|
|
|
|
Item 1 – |
|
Financial Statements (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets – March 31, 2019 and December 31, 2018 |
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2019 and 2018 |
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
6 |
||
|
|||||||
|
|
|
|
Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2019 and 2018 |
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
||
|
|
|
|
|
|
|
|
|
|
Item 2 – |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
21 |
|
|
|
|
|
|
|
|
|
|
|
Item 3 – |
|
|
25 |
||
|
|
|
|
|
|
|
|
|
|
Item 4 – |
|
|
25 |
||
|
|
|
|
|
|
|
|
Part II – |
|
Other Information: |
|
|
|||
|
|
|
|
|
|||
|
|
Item 1 – |
|
|
26 |
||
|
|
|
|
|
|
|
|
|
|
Item 1A – |
|
|
26 |
||
|
|
|
|
|
|
|
|
|
|
Item 6 – |
|
|
26 |
||
|
|
|
|
|
|
|
|
|
27 |
||||||
|
|
|
|
|
|
|
2
PART I – FINANCIAL INFORMATION
AMPCO-PITTSBURGH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(in thousands, except par value)
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
10,443 |
|
|
$ |
19,713 |
|
Receivables, less allowance for doubtful accounts of $1,028 in 2019 and $978 in 2018 |
|
|
86,557 |
|
|
|
69,448 |
|
Inventories |
|
|
93,433 |
|
|
|
94,196 |
|
Insurance receivable – asbestos |
|
|
17,000 |
|
|
|
17,000 |
|
Other current assets |
|
|
6,085 |
|
|
|
7,271 |
|
Current assets of discontinued operations |
|
|
17,754 |
|
|
|
20,238 |
|
Total current assets |
|
|
231,272 |
|
|
|
227,866 |
|
Property, plant and equipment, net |
|
|
173,492 |
|
|
|
185,661 |
|
Operating lease right-of-use assets |
|
|
5,823 |
|
|
|
0 |
|
Insurance receivable – asbestos |
|
|
133,093 |
|
|
|
135,508 |
|
Deferred income tax assets |
|
|
2,934 |
|
|
|
3,188 |
|
Intangible assets, net |
|
|
8,527 |
|
|
|
9,225 |
|
Investments in joint ventures |
|
|
2,175 |
|
|
|
2,175 |
|
Other noncurrent assets |
|
|
7,935 |
|
|
|
7,496 |
|
Total assets |
|
$ |
565,251 |
|
|
$ |
571,119 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
45,807 |
|
|
$ |
38,900 |
|
Accrued payrolls and employee benefits |
|
|
19,031 |
|
|
|
20,380 |
|
Debt – current portion |
|
|
19,256 |
|
|
|
45,728 |
|
Operating lease liabilities – current portion |
|
|
518 |
|
|
|
0 |
|
Asbestos liability – current portion |
|
|
24,000 |
|
|
|
24,000 |
|
Other current liabilities |
|
|
29,918 |
|
|
|
28,987 |
|
Current liabilities of discontinued operations |
|
|
9,786 |
|
|
|
9,458 |
|
Total current liabilities |
|
|
148,316 |
|
|
|
167,453 |
|
Employee benefit obligations |
|
|
66,443 |
|
|
|
72,658 |
|
Asbestos liability |
|
|
201,133 |
|
|
|
203,922 |
|
Deferred income tax liabilities |
|
|
256 |
|
|
|
164 |
|
Long-term debt |
|
|
58,061 |
|
|
|
31,881 |
|
Noncurrent operating lease liabilities |
|
|
5,305 |
|
|
|
0 |
|
Other noncurrent liabilities |
|
|
2,003 |
|
|
|
2,072 |
|
Total liabilities |
|
|
481,517 |
|
|
|
478,150 |
|
Commitments and contingent liabilities (Note 9) |
|
|
|
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
|
|
|
|
Common stock – par value $1; authorized 20,000 shares; issued and outstanding 12,513 shares in 2019 and 12,495 shares in 2018 |
|
|
12,513 |
|
|
|
12,495 |
|
Additional paid-in capital |
|
|
155,283 |
|
|
|
154,889 |
|
Retained deficit |
|
|
(45,503 |
) |
|
|
(30,355 |
) |
Accumulated other comprehensive loss |
|
|
(44,421 |
) |
|
|
(49,434 |
) |
Total Ampco-Pittsburgh shareholders’ equity |
|
|
77,872 |
|
|
|
87,595 |
|
Noncontrolling interest |
|
|
5,862 |
|
|
|
5,374 |
|
Total shareholders’ equity |
|
|
83,734 |
|
|
|
92,969 |
|
Total liabilities and shareholders’ equity |
|
$ |
565,251 |
|
|
$ |
571,119 |
|
See Notes to Condensed Consolidated Financial Statements.
3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(in thousands, except per share amounts)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Net sales |
|
$ |
107,494 |
|
|
$ |
106,415 |
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
Costs of products sold (excluding depreciation and amortization) |
|
|
90,221 |
|
|
|
87,653 |
|
Selling and administrative |
|
|
13,885 |
|
|
|
14,856 |
|
Depreciation and amortization |
|
|
5,259 |
|
|
|
5,600 |
|
Impairment charge |
|
|
10,082 |
|
|
|
0 |
|
Loss on disposal of assets |
|
|
6 |
|
|
|
83 |
|
Total operating expenses |
|
|
119,453 |
|
|
|
108,192 |
|
Loss from continuing operations |
|
|
(11,959 |
) |
|
|
(1,777 |
) |
Other income (expense): |
|
|
|
|
|
|
|
|
Investment-related income |
|
|
40 |
|
|
|
24 |
|
Interest expense |
|
|
(1,285 |
) |
|
|
(873 |
) |
Other – net |
|
|
1,296 |
|
|
|
3,621 |
|
|
|
|
51 |
|
|
|
2,772 |
|
(Loss) income from continuing operations before income taxes |
|
|
(11,908 |
) |
|
|
995 |
|
Income tax (provision) benefit |
|
|
(643 |
) |
|
|
463 |
|
Net (loss) income from continuing operations |
|
|
(12,551 |
) |
|
|
1,458 |
|
Loss from discontinued operations, net of tax |
|
|
(2,242 |
) |
|
|
(69 |
) |
Net (loss) income |
|
|
(14,793 |
) |
|
|
1,389 |
|
Less: Net income attributable to noncontrolling interest |
|
|
355 |
|
|
|
448 |
|
Net (loss) income attributable to Ampco-Pittsburgh |
|
$ |
(15,148 |
) |
|
$ |
941 |
|
|
|
|
|
|
|
|
|
|
Net (loss) income from continuing operations per common share: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
(1.00 |
) |
|
$ |
0.12 |
|
Diluted |
|
$ |
(1.00 |
) |
|
$ |
0.12 |
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, net of tax, per common share: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.18 |
) |
|
$ |
(0.01 |
) |
Diluted |
|
$ |
(0.18 |
) |
|
$ |
(0.01 |
) |
|
|
|
|
|
|
|
|
|
Net (loss) income per common share attributable to Ampco-Pittsburgh: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
(1.21 |
) |
|
$ |
0.08 |
|
Diluted |
|
$ |
(1.21 |
) |
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
|
12,497 |
|
|
|
12,362 |
|
Diluted |
|
|
12,497 |
|
|
|
12,379 |
|
See Notes to Condensed Consolidated Financial Statements.
4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)
(in thousands)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Net (loss) income |
|
$ |
(14,793 |
) |
|
$ |
1,389 |
|
Other comprehensive income (loss), net of income tax where applicable: |
|
|
|
|
|
|
|
|
Adjustments for changes in: |
|
|
|
|
|
|
|
|
Foreign currency translation |
|
|
449 |
|
|
|
2,498 |
|
Unrecognized employee benefit costs (including effects of foreign currency translation) |
|
|
4,149 |
|
|
|
(413 |
) |
Fair value of cash flow hedges |
|
|
268 |
|
|
|
(315 |
) |
Reclassification adjustments for items included in net (loss) income: |
|
|
|
|
|
|
|
|
Amortization of unrecognized employee benefit costs |
|
|
161 |
|
|
|
130 |
|
Realized losses (gains) from settlement of cash flow hedges |
|
|
119 |
|
|
|
(209 |
) |
Other comprehensive income |
|
|
5,146 |
|
|
|
1,691 |
|
Comprehensive (loss) income |
|
|
(9,647 |
) |
|
|
3,080 |
|
Less: Comprehensive income attributable to noncontrolling interest |
|
|
488 |
|
|
|
599 |
|
Comprehensive (loss) income attributable to Ampco-Pittsburgh |
|
$ |
(10,135 |
) |
|
$ |
2,481 |
|
See Notes to Condensed Consolidated Financial Statements.
5
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(UNAUDITED)
(in thousands)
|
|
Common Stock |
|
|
Additional Paid-in Capital |
|
|
Retained Earnings (Deficit) |
|
|
Accumulated Other Comprehensive Loss |
|
|
Noncontrolling Interest |
|
|
Total |
|
||||||
Balance January 1, 2018 |
|
$ |
12,361 |
|
|
$ |
152,992 |
|
|
$ |
38,980 |
|
|
$ |
(45,392 |
) |
|
$ |
2,820 |
|
|
$ |
161,761 |
|
Stock-based compensation |
|
|
|
|
|
|
444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
444 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
941 |
|
|
|
|
|
|
|
448 |
|
|
|
1,389 |
|
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,540 |
|
|
|
151 |
|
|
|
1,691 |
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
599 |
|
|
|
3,080 |
|
Other |
|
|
1 |
|
|
|
(1 |
) |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
Balance March 31, 2018 |
|
$ |
12,362 |
|
|
$ |
153,435 |
|
|
$ |
39,921 |
|
|
$ |
(43,851 |
) |
|
$ |
3,419 |
|
|
$ |
165,286 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance January 1, 2019 |
|
$ |
12,495 |
|
|
$ |
154,889 |
|
|
$ |
(30,355 |
) |
|
$ |
(49,434 |
) |
|
$ |
5,374 |
|
|
$ |
92,969 |
|
Stock-based compensation |
|
|
|
|
|
|
340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
340 |
|
Comprehensive (loss) income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
|
|
|
|
|
|
|
|
|
(15,148 |
) |
|
|
|
|
|
|
355 |
|
|
|
(14,793 |
) |
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,013 |
|
|
|
133 |
|
|
|
5,146 |
|
Comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
488 |
|
|
|
(9,647 |
) |
Issuance of common stock including excess tax benefits of $0 |
|
|
18 |
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72 |
|
Balance March 31, 2019 |
|
$ |
12,513 |
|
|
$ |
155,283 |
|
|
$ |
(45,503 |
) |
|
$ |
(44,421 |
) |
|
$ |
5,862 |
|
|
$ |
83,734 |
|
See Notes to Condensed Consolidated Financial Statements.
6
AMPCO-PITTSBURGH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(in thousands)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Net cash flows used in operating activities - continuing operations |
|
$ |
(7,089 |
) |
|
$ |
(9,600 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment |
|
|
(1,379 |
) |
|
|
(1,453 |
) |
Purchases of long-term marketable securities |
|
|
(12 |
) |
|
|
(89 |
) |
Proceeds from sale of long-term marketable securities |
|
|
80 |
|
|
|
128 |
|
Net cash flows used in investing activities - continuing operations |
|
|
(1,311 |
) |
|
|
(1,414 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Repayment of debt |
|
|
(27,080 |
) |
|
|
(178 |
) |
Proceeds from Revolving Credit and Security Agreement |
|
|
29,217 |
|
|
|
16,052 |
|
Payments on Revolving Credit and Security Agreement |
|
|
(3,500 |
) |
|
|
0 |
|
Funding of discontinued operations |
|
|
573 |
|
|
|
(2,256 |
) |
Net cash flows (used in) provided by financing activities - continuing operations |
|
|
(790 |
) |
|
|
13,618 |
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
(80 |
) |
|
|
142 |
|
|
|
|
|
|
|
|
|
|
Cash flows from discontinued operations: |
|
|
|
|
|
|
|
|
Net cash flows provided by (used in) operating activities - discontinued operations |
|
|
108 |
|
|
|
(1,252 |
) |
Net cash flows used in investing activities - discontinued operations |
|
|
(264 |
) |
|
|
(1,496 |
) |
Net cash flows (used in) provided by financing activities - discontinued operations |
|
|
(573 |
) |
|
|
2,256 |
|
Net cash flows used in discontinued operations |
|
|
(729 |
) |
|
|
(492 |
) |
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents |
|
|
(9,999 |
) |
|
|
2,254 |
|
Cash and cash equivalents at beginning of period |
|
|
20,837 |
|
|
|
20,700 |
|
Cash and cash equivalents at end of period |
|
|
10,838 |
|
|
|
22,954 |
|
Less: cash and cash equivalents of discontinued operations |
|
|
(395 |
) |
|
|
(1,552 |
) |
Cash and cash equivalents of continuing operations at end of period |
|
$ |
10,443 |
|
|
$ |
21,402 |
|
|
|
|
|
|
|
|
|
|
Supplemental information: |
|
|
|
|
|
|
|
|
Income tax payments |
|
$ |
212 |
|
|
$ |
82 |
|
Interest payments |
|
$ |
370 |
|
|
$ |
240 |
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment included in accounts payable |
|
$ |
780 |
|
|
$ |
737 |
|
Finance lease right-of-use assets exchanged for lease liabilities |
|
$ |
453 |
|
|
$ |
0 |
|
See Notes to Condensed Consolidated Financial Statements.
7
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
(in thousands, except share amounts)
1. |
Unaudited Condensed Consolidated Financial Statements |
The condensed consolidated balance sheet as of March 31, 2019, and the condensed consolidated statements of operations, comprehensive income (loss), shareholders’ equity and cash flows for the three months ended March 31, 2019, and 2018, have been prepared by Ampco-Pittsburgh Corporation (the “Corporation”) without audit. In the opinion of management, all adjustments, consisting of only normal and recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. The results of operations for the three months ended March 31, 2019, are not necessarily indicative of the operating results expected for the full year.
In October 2018, the Board of Directors of the Corporation approved a plan to sell ASW Steel Inc. (“ASW”). See Note 2. Accordingly, the Corporation has presented the assets and liabilities of ASW as of March 31, 2019, and December 31, 2018, and its operating results and cash flows for the three months ended March 31, 2019, and 2018, as discontinued operations in the accompanying financial statements. All footnotes exclude balances and activity of ASW unless otherwise noted.
Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted.
Recently Implemented Accounting Pronouncements
In August 2017, the Financial Accounting Standards Board (“FASB”) issued ASU 2017-12, Derivatives and Hedging, which amends and simplifies existing guidance to allow companies to present more accurately the economic effects of risk management activities in the financial statements. The amended guidance became effective for the Corporation on January 1, 2019, and did not affect the Corporation’s financial position, operating results or liquidity.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use (“ROU”) asset and lease liability for all leases other than those with a term less than one year and to disclose key information about certain leasing arrangements. The guidance became effective for the Corporation on January 1, 2019, and was applied on a modified retrospective basis (cumulative-effect adjustment to January 1, 2019 retained earnings). An operating lease ROU asset and operating lease liability equal to the present value of lease payments of $5,893 was recorded as of January 1, 2019. There was no cumulative-effect adjustment to the Corporation’s retained earnings as of January 1, 2019, since initial direct costs were insignificant. See Note 4 and Note 7, respectively, for the finance lease ROU assets recorded within Property, Plant and Equipment and the finance lease liabilities recorded within Debt as of March 31, 2019. ASU 2016-02 also provides an election for practical expedients which permit an entity not to reassess whether any expired or existing contracts contain leases, to carry forward the existing lease classification, and not to reassess initial direct costs associated with existing leases. The Corporation applied these practical expedients as part of its adoption. The new guidance did not affect the Corporation’s operating results or liquidity.
Recently Issued Accounting Pronouncements
There have been no recently issued accounting pronouncements applicable to the Corporation.
2. |
Discontinued Operations and Disposition |
In 2016, the Corporation purchased the stock of ASW, a specialty steel producer based in Canada. The acquisition supported the Corporation’s diversification efforts in the open-die forging market. Loss of significant U.S. business due to a combination of tariffs imposed by the United States on imports of primary steel and loss of a key customer as a result of a plant closure have resulted in significant losses for the Canadian operation. In October 2018, the Board of Directors of the Corporation approved a plan to sell ASW. While the Corporation will continue to service the open-die forged products market, it will not have a dedicated supply of required specialty steel through a back-end integration of ASW. Additionally, the Corporation will no longer manufacture and supply primary specialty steels to customers in the non-roll opened and closed die forgings and rebar markets and will exit the Canadian market.
Collectively, the sale of ASW represents a strategic shift that will have a major impact on the Corporation’s operations and financial results. As of December 31, 2018, the “asset held for sale” and “discontinued operations” criteria were met. Accordingly, as set forth in ASC 205, Presentation of Financial Statements, the assets and liabilities of ASW have been presented separately as assets and liabilities of discontinued operations in the accompanying condensed consolidated balance sheets as of March 31, 2019, and December 31, 2018. The assets and liabilities of ASW are classified as current because the Corporation expects to complete the sale in 2019. Additionally, the operating results and cash flows of ASW have been presented as discontinued operations, for the current and prior year period, in the accompanying condensed consolidated statements of operations and statements of cash flows. Previously, the operating results of ASW were included in the operating results of the Forged and Cast Engineered Products segment.
8
The assets and liabilities of ASW were as follows as of March 31, 2019, and December 31, 2018:
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Cash and cash equivalents |
|
$ |
395 |
|
|
$ |
1,124 |
|
Receivables |
|
|
7,303 |
|
|
|
6,928 |
|
Inventories |
|
|
11,780 |
|
|
|
13,764 |
|
Other assets |
|
|
1,463 |
|
|
|
1,708 |
|
Property, plant and equipment, net |
|
|
11,813 |
|
|
|
11,714 |
|
Estimated charge for impairment |
|
|
(15,000 |
) |
|
|
(15,000 |
) |
Current assets of discontinued operations |
|
$ |
17,754 |
|
|
$ |
20,238 |
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
9,123 |
|
|
$ |
8,890 |
|
Accrued payrolls and employee benefits |
|
|
140 |
|
|
|
178 |
|
Other current liabilities |
|
|
523 |
|
|
|
390 |
|
Current liabilities of discontinued operations |
|
$ |
9,786 |
|
|
$ |
9,458 |
|
The following table presents the major classes of ASW’s line items constituting the “loss from discontinued operations, net of tax” in the condensed consolidated statements of operations for the three months ended March 31:
|
|
2019 |
|
|
2018 |
|
||
Net sales |
|
$ |
15,045 |
|
|
$ |
22,334 |
|
Costs of products sold (excluding depreciation and amortization) |
|
|
16,758 |
|
|
|
20,776 |
|
Selling and administrative |
|
|
549 |
|
|
|
617 |
|
Depreciation and amortization |
|
|
0 |
|
|
|
305 |
|
Gain on disposal of assets |
|
|
0 |
|
|
|
(38 |
) |
(Loss) income from discontinued operations |
|
|
(2,262 |
) |
|
|
674 |
|
Other income (expense) |
|
|
20 |
|
|
|
(721 |
) |
Loss from discontinued operations before income taxes |
|
|
(2,242 |
) |
|
|
(47 |
) |
Income tax provision |
|
|
0 |
|
|
|
(22 |
) |
Loss from discontinued operations, net of tax |
|
$ |
(2,242 |
) |
|
$ |
(69 |
) |
Net sales for the three months ended March 31, 2019, and 2018, include $3,138 and $13,672, respectively, of products sold by ASW to Union Electric Steel Corporation (“UES”), a subsidiary of the Corporation. Costs of products sold (excluding depreciation and amortization) approximated the same. In connection with the sale, the Corporation expects to enter into a long-term supply agreement for the supply of steel ingots.
Additionally, in March 2019, the Board of Directors of the Corporation approved a plan to sell certain assets of the Corporation’s Avonmore, Pennsylvania, cast roll manufacturing facility owned by Akers National Roll Company. In connection with the anticipated disposal, the Corporation recognized an impairment loss of $10,082 to record the assets to their estimated net realizable value. See Note 18.
3. |
Inventories |
At March 31, 2019, and December 31, 2018, approximately 33% and 36%, respectively, of the inventories were valued on the LIFO method with the remaining inventories valued on the FIFO method. Inventories were comprised of the following:
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Raw materials |
|
$ |
20,813 |
|
|
$ |
19,615 |
|
Work-in-process |
|
|
42,311 |
|
|
|
42,339 |
|
Finished goods |
|
|
18,757 |
|
|
|
20,650 |
|
Supplies |
|
|
11,552 |
|
|
|
11,592 |
|
Inventories |
|
$ |
93,433 |
|
|
$ |
94,196 |
|
9
Property, plant and equipment were comprised of the following:
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Land and land improvements |
|
$ |
9,934 |
|
|
$ |
10,207 |
|
Buildings |
|
|
62,113 |
|
|
|
65,425 |
|
Machinery and equipment |
|
|
321,146 |
|
|
|
332,378 |
|
Construction-in-process |
|
|
4,289 |
|
|
|
3,499 |
|
Other |
|
|
6,811 |
|
|
|
6,813 |
|
|
|
|
404,293 |
|
|
|
418,322 |
|
Accumulated depreciation and amortization |
|
|
(230,801 |
) |
|
|
(232,661 |
) |
Property, plant and equipment, net |
|
$ |
173,492 |
|
|
$ |
185,661 |
|
The majority of the assets of the Corporation, except real property, is pledged as collateral for the Corporation’s Revolving Credit and Security Agreement (Note 7). Land and buildings of Union Electric Steel UK Limited (“UES-UK”), equal to approximately $2,733 (£2,098) at March 31, 2019, are held as collateral by the trustees of the UES-UK defined benefit pension plan (Note 8). The gross value of finance lease ROU assets and the related accumulated amortization as of March 31, 2019, approximated $3,687 and $967, respectively, and at December 31, 2018, approximated $3,716 and $1,340, respectively.
5. |
Intangible Assets |
Intangible assets were comprised of the following:
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Customer relationships |
|
$ |
6,019 |
|
|
$ |
6,234 |
|
Developed technology |
|
|
4,105 |
|
|
|
4,322 |
|
Trade name |
|
|
2,371 |
|
|
|
2,497 |
|
|
|
|
12,495 |
|
|
|
13,053 |
|
Accumulated amortization |
|
|
(3,968 |
) |
|
|
(3,828 |
) |
Intangible assets, net |
|
$ |
8,527 |
|
|
$ |
9,225 |
|
The following summarizes changes in intangible assets:
|
Three Months Ended March 31, |
|
|||||
|
2019 |
|
|
2018 |
|
||
Balance at beginning of period |
$ |
9,225 |
|
|
$ |
11,021 |
|
Changes in intangible assets (Akers National Roll) |
|
(292 |
) |
|
|
0 |
|
Amortization of intangible assets |
|
(298 |
) |
|
|
(314 |
) |
Other, primarily impact from changes in foreign currency exchange rates |
|
(108 |
) |
|
|
35 |
|
Balance at end of period |
$ |
8,527 |
|
|
$ |
10,742 |
|
Changes during the three months ended March 31, 2019, represent an impairment charge on intangible assets of Akers National Roll Company.
6. |
Other Current Liabilities |
Other current liabilities were comprised of the following:
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Customer-related liabilities |
|
$ |
15,462 |
|
|
$ |
16,439 |
|
Accrued interest payable |
|
|
2,519 |
|
|
|
2,333 |
|
Accrued sales commissions |
|
|
1,683 |
|
|
|
1,637 |
|
Other |
|
|
10,254 |
|
|
|
8,578 |
|
Other current liabilities |
|
$ |
29,918 |
|
|
$ |
28,987 |
|
10
Included in customer-related liabilities are costs expected to be incurred with respect to product warranties and customer deposits. The Corporation provides a limited warranty on its products, known as assurance type warranties, and may issue credit notes or replace products free of charge for valid claims. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended. Historically, warranty claims have been insignificant. The Corporation records a provision for product warranties at the time the underlying sale is recorded. The provision is based on historical experience as a percent of sales adjusted for potential claims when a liability is probable and for known claims.
Changes in the liability for product warranty claims consisted of the following:
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Balance at beginning of the period |
|
$ |
9,447 |
|
|
$ |
11,379 |
|
Satisfaction of warranty claims |
|
|
(1,469 |
) |
|
|
(1,792 |
) |
Provision for warranty claims |
|
|
1,450 |
|
|
|
893 |
|
Other, primarily impact from changes in foreign currency exchange rates |
|
|
(64 |
) |
|
|
38 |
|
Balance at end of the period |
|
$ |
9,364 |
|
|
$ |
10,518 |
|
Customer deposits represent amounts collected from, or invoiced to, a customer in advance of revenue recognition, and are recorded as an other current liability on the balance sheet. The liability for customer deposits is reversed when the Corporation satisfies its performance obligations and control of the inventory transfers to the customer, typically when title transfers. Performance obligations related to customer deposits are expected to be satisfied in less than one year.
Changes in customer deposits consisted of the following:
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Balance at beginning of the period |
|
$ |
4,304 |
|
|
$ |
4,574 |
|
Satisfaction of performance obligations |
|
|
(3,934 |
) |
|
|
(2,512 |
) |
Receipt of additional deposits |
|
|
2,738 |
|
|
|
2,637 |
|
Other, primarily changes in foreign currency exchange rates |
|
|
(77 |
) |
|
|
3 |
|
Balance at end of the period |
|
$ |
3,031 |
|
|
$ |
4,702 |
|
7. |
Borrowing Arrangements |
Borrowings consisted of the following: |
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Revolving Credit and Security Agreement |
|
$ |
40,037 |
|
|
$ |
14,320 |
|
Sale and leaseback financing obligation |
|
|
18,626 |
|
|
|
18,518 |
|
Promissory notes (and interest) |
|
|
0 |
|
|
|
26,205 |
|
Industrial Revenue Bonds ("IRB") |
|
|
13,311 |
|
|
|
13,311 |
|
Minority shareholder loan |
|
|
3,858 |
|
|
|
4,056 |
|
Finance lease liabilities |
|
|
1,485 |
|
|
|
1,199 |
|
Outstanding borrowings |
|
|
77,317 |
|
|
|
77,609 |
|
Debt – current portion |
|
|
(19,256 |
) |
|
|
(45,728 |
) |
Long-term debt |
|
$ |
58,061 |
|
|
$ |
31,881 |
|
11
Revolving Credit and Security Agreement
The Corporation is party to a five-year Revolving Credit and Security Agreement (the “Credit Agreement”) with a syndicate of banks, which expires in May 2021. The Credit Agreement provides for initial borrowings not to exceed $100,000, with an option to increase the credit facility by an additional $50,000 at the request of the Corporation and with the approval of the banks. The Credit Agreement includes sublimits for letters of credit not to exceed $40,000, European borrowings not to exceed $15,000, and Canadian borrowings not to exceed $15,000.
Availability under the Credit Agreement is based on eligible accounts receivable, inventory and fixed assets. Amounts outstanding under the credit facility bear interest, at the Corporation’s option, at either (i) LIBOR plus an applicable margin ranging between 1.75% to 2.25% based on the quarterly average excess availability or (ii) the base rate plus an applicable margin ranging between 0.75% to 1.25% based on the quarterly average excess availability. Additionally, the Corporation is required to pay a commitment fee ranging between 0.25% and 0.375% based on the daily unused portion of the credit facility. As of March 31, 2019, the Corporation had outstanding borrowings under the Credit Agreement of $40,037 (including £3,000 of European borrowings for its U.K. subsidiary). Outstanding borrowings increased from December 31, 2018, to March 31, 2019, due to additional borrowings used to repay promissory notes in March 2019. The average interest rate for the three months ended March 31, 2019, was approximately 2.22%. Additionally, the Corporation had utilized a portion of the credit facility for letters of credit (Note 9). As of March 31, 2019, remaining availability under the Credit Agreement approximated $39,000, net of standard availability reserves.
Borrowings outstanding under the Credit Agreement are collateralized by a first priority perfected security interest in substantially all of the assets of the Corporation and its subsidiaries (other than real property). Additionally, the Credit Agreement contains customary affirmative and negative covenants and limitations, including, but not limited to, investments in certain of its subsidiaries, payment of dividends, incurrence of additional indebtedness, upstream distributions from subsidiaries, and acquisitions and divestures. The Corporation must also maintain a certain level of excess availability. If excess availability falls below the established threshold, or in an event of default, the Corporation will be required to maintain a minimum fixed charge coverage ratio of not less than 1.00 to 1.00. The Corporation was in compliance with the applicable bank covenants as of March 31, 2019.
Sale and Leaseback Financing Obligation
In September 2018, UES completed a sale and leaseback financing transaction for certain of its real property, including its manufacturing facilities in Valparaiso, Indiana and Burgettstown, Pennsylvania, and its manufacturing facility and corporate headquarters located in Carnegie, Pennsylvania (the “Properties”). Simultaneously with the sale, UES entered into a lease agreement pursuant to which UES leased the Properties from the buyer. The lease provides for an initial term of 20 years; however, UES may extend the lease for four successive periods of approximately five years each. If fully extended, the lease would expire in September 2058. UES also has the option to repurchase the Properties, which it may exercise in 2025, for a price equal to the greater of (i) their Fair Market Value, or (ii) 115% of Lessor’s Total Investment for the Facilities, with such terms defined in the lease agreement. The effective interest rate approximated 6% for the three months ended March 31, 2019.
Promissory Notes
In connection with a March 2016 acquisition, the Corporation issued two three-year promissory notes. Principal and accrued interest of $26,474, in the aggregate, were paid on March 4, 2019, using additional borrowings under the Credit Agreement.
8. Pension and Other Postretirement Benefits
In 2019, the Corporation amended retiree health benefits for one of its other postretirement benefit plans to a stipend and reimbursement plan, with the amendment becoming effective in 2020. Additionally, future hires will be no longer eligible for retiree medical or life insurance. Changes to retiree health benefits resulted in a remeasurement of the liability, reducing the liability by $4,632, and a curtailment gain of $15.
Contributions were as follows:
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
U.S. defined benefit pension plans |
|
$ |
253 |
|
|
$ |
0 |
|
Foreign defined benefit pension plans |
|
|
93 |
|
|
|
540 |
|
Other postretirement benefits (e.g., net payments) |
|
|
266 |
|
|
|
307 |
|
U.K. defined contribution pension plan |
|
|
85 |
|
|
|
91 |
|
U.S. defined contribution plan |
|
|
625 |
|
|
|
705 |
|
12
Net periodic pension and other postretirement benefit costs include the following components:
|
|
Three Months Ended March 31, |
|
|||||
U.S. Defined Benefit Pension Plans |
|
2019 |
|
|
2018 |
|
||
Service cost |
|
$ |
194 |
|
|
$ |
335 |
|
Interest cost |
|
|
2,220 |
|
|
|
2,040 |
|
Expected return on plan assets |
|
|
(3,173 |
) |
|
|
(3,284 |
) |
Amortization of prior service cost |
|
|
9 |
|
|
|
13 |
|
Amortization of actuarial loss |
|
|
308 |
|
|
|
475 |
|
Net benefit income |
|
$ |
(442 |
) |
|
$ |
(421 |
) |
|
|
Three Months Ended March 31, |
|
|||||
Foreign Defined Benefit Pension Plans |
|
2019 |
|
|
2018 |
|
||
Service cost |
|
$ |
102 |
|
|
$ |
111 |
|
Interest cost |
|
|
357 |
|
|
|
364 |
|
Expected return on plan assets |
|
|
(591 |
) |
|
|
(672 |
) |
Amortization of prior service credit |
|
|
(72 |
) |
|
|
(88 |
) |
Amortization of actuarial loss |
|
|
166 |
|
|
|
194 |
|
Net benefit income |
|
$ |
(38 |
) |
|
$ |
(91 |
) |
|
|
Three Months Ended March 31, |
|
|||||
Other Postretirement Benefit Plans |
|
2019 |
|
|
2018 |
|
||
Service cost |
|
$ |
88 |
|
|
$ |
102 |
|
Interest cost |
|
|
105 |
|
|
|
125 |
|
Amortization of prior service credit |
|
|
(489 |
) |
|
|
(402 |
) |
Amortization of actuarial gain |
|
|
(83 |
) |
|
|
(62 |
) |
Curtailment gain |
|
|
(15 |
) |
|
|
0 |
|
Net benefit income |
|
$ |
(394 |
) |
|
$ |
(237 |
) |
9. |
Commitments and Contingent Liabilities |
Outstanding standby and commercial letters of credit as of March 31, 2019, approximated $18,850, the majority of which serves as collateral for the IRB debt. In addition, the Corporation issued two surety bonds approximating $4,000 (SEK 33,900) to guarantee certain obligations under a credit insurance arrangement for certain of its foreign pension commitments.
See Note 11 for derivative instruments, Note 15 for litigation and Note 16 for environmental matters.
10. |
Accumulated Other Comprehensive Loss |
Net change and ending balances for the various components of accumulated other comprehensive loss as of and for the three months ended March 31, 2019, and 2018, is summarized below. All amounts are net of tax, where applicable.
|
|
Foreign Currency Translation Adjustments |
|
|
Unrecognized Employee Benefit Costs |
|
|
Cash Flow Hedges |
|
|
Accumulated Other Comprehensive Loss |
|
||||
Balance at January 1, 2019 |
|
$ |
(18,642 |
) |
|
$ |
(30,902 |
) |
|
$ |
(64 |
) |
|
$ |
(49,608 |
) |
Net Change |
|
|
449 |
|
|
|
4,310 |
|
|
|
387 |
|
|
|
5,146 |
|
Balance at March 31, 2019 |
|
$ |
(18,193 |
) |
|
$ |
(26,592 |
) |
|
$ |
323 |
|
|
$ |
(44,462 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1, 2018 |
|
$ |
(11,932 |
) |
|
$ |
(34,196 |
) |
|
$ |
739 |
|
|
$ |
(45,389 |
) |
Net Change |
|
|
2,498 |
|
|
|
(283 |
) |
|
|
(524 |
) |
|
|
1,691 |
|
Balance at March 31, 2018 |
|
$ |
(9,434 |
) |
|
$ |
(34,479 |
) |
|
$ |
215 |
|
|
$ |
(43,698 |
) |
13
The following summarizes the line items affected on the condensed consolidated statements of operations for components reclassified from accumulated other comprehensive loss. Amounts in parentheses represent credits to net income (loss). There was no income tax benefit or expense associated with the various components of other comprehensive income (loss) for either of the periods, due to the Corporation having a valuation allowance recorded against its deferred income tax assets for the jurisdiction where the expense is recognized. Foreign currency translation adjustments exclude the effect of income taxes since earnings of non-U.S. subsidiaries are deemed to be reinvested for an indefinite period of time.
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Amortization of unrecognized employee benefit costs: |
|
|
|
|
|
|
|
|
Other income |
|
$ |
161 |
|
|
$ |
130 |
|
Income tax provision |
|
|
0 |
|
|
|
0 |
|
Net of tax |
|
$ |
161 |
|
|
$ |
130 |
|
Realized gains/losses from settlement of cash flow hedges: |
|
|
|
|
|
|
|
|
Depreciation and amortization (foreign currency purchase contracts) |
|
$ |
(7 |
) |
|
$ |
(7 |
) |
Costs of products sold (excluding depreciation and amortization) (futures contracts – copper and aluminum) |
|
|
126 |
|
|
|
(202 |
) |
Total before income tax |
|
|
119 |
|
|
|
(209 |
) |
Income tax provision |
|
|
0 |
|
|
|
0 |
|
Net of tax |
|
$ |
119 |
|
|
$ |
(209 |
) |
11. |
Derivative Instruments |
Certain of the Corporation’s operations are subject to risk from exchange rate fluctuations in connection with sales in foreign currencies. To minimize this risk, foreign currency sales contracts are entered into which are designated as cash flow or fair value hedges. As of March 31, 2019, approximately $20,917 of anticipated foreign-denominated sales has been hedged which are covered by fair value contracts settling at various dates through January 2020.
Additionally, certain of the divisions of the Air and Liquid Processing segment are subject to risk from increases in the price of commodities (copper and aluminum) used in the production of inventory. To minimize this risk, futures contracts are entered into which are designated as cash flow hedges. At March 31, 2019, approximately 49% or $2,389 of anticipated copper purchases over the next 10 months and 56% or $496 of anticipated aluminum purchases over the next six months are hedged.
The Corporation previously entered into foreign currency purchase contracts to manage the volatility associated with Euro-denominated progress payments to be made for certain machinery and equipment. As of December 31, 2010, all contracts had been settled and the underlying fixed assets were placed in service.
No portion of the existing cash flow or fair value hedges is considered to be ineffective, including any ineffectiveness arising from the unlikelihood of an anticipated transaction to occur. Additionally, no amounts have been excluded from assessing the effectiveness of a hedge.
The Corporation does not enter into derivative transactions for speculative purposes and, therefore, holds no derivative instruments for trading purposes.
Losses on foreign exchange transactions included in other income (expense) approximated $348 and $67 for the three months ended March 31, 2019, and 2018, respectively.
The location and fair value of the foreign currency sales contracts recorded on the condensed consolidated balance sheets were as follows:
|
|
Location |
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
Fair value hedge contracts |
|
Other current assets |
|
$ |
190 |
|
|
$ |
44 |
|
|
|
Other current liabilities |
|
|
361 |
|
|
|
950 |
|
|
|
Other noncurrent liabilities |
|
|
0 |
|
|
|
70 |
|
Fair value hedged items |
|
Receivables |
|
|
686 |
|
|
|
232 |
|
|
|
Other current assets |
|
|
362 |
|
|
|
967 |
|
|
|
Other noncurrent assets |
|
|
0 |
|
|
|
105 |
|
|
|
Other current liabilities |
|
|
660 |
|
|
|
12 |
|
14
The change in the fair value of the cash flow contracts is recorded as a component of accumulated other comprehensive loss. The balances as of March 31, 2019, and 2018, and the amount recognized as and reclassified from accumulated other comprehensive loss for each of the periods is summarized below. Amounts recognized as comprehensive income (loss) and reclassified from accumulated other comprehensive loss have no tax effect due to deferred income tax assets being fully valued in the related jurisdictions.
Three Months Ended March 31, 2019 |
|
Beginning of the Period |
|
|
Recognized |
|
|
Reclassified |
|
|
End of the Period |
|
||||
Foreign currency purchase contracts |
|
$ |
216 |
|
|
$ |
0 |
|
|
$ |
7 |
|
|
$ |
209 |
|
Futures contracts – copper and aluminum |
|
|
(280 |
) |
|
|
268 |
|
|
|
(126 |
) |
|
|
114 |
|
|
|
$ |
(64 |
) |
|
$ |
268 |
|
|
$ |
(119 |
) |
|
$ |
323 |
|
Three Months Ended March 31, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency purchase contracts |
|
$ |
239 |
|
|
$ |
0 |
|
|
$ |
7 |
|
|
$ |
232 |
|
Futures contracts – copper and aluminum |
|
|
500 |
|
|
|
(315 |
) |
|
|
202 |
|
|
|
(17 |
) |
|
|
$ |
739 |
|
|
$ |
(315 |
) |
|
$ |
209 |
|
|
$ |
215 |
|
The change in fair value reclassified or expected to be reclassified from accumulated other comprehensive loss to earnings is summarized below. All amounts are pre-tax.
|
|
Location of Gain (Loss) in Statements |
|
Estimated to be Reclassified in the Next |
|
|
Three Months Ended March 31, |
|
||||||
|
|
of Operations |
|
12 Months |
|
|
2019 |
|
|
2018 |
|
|||
Foreign currency purchase contracts |
|
Depreciation and amortization |
|
$ |
27 |
|
|
$ |
7 |
|
|
$ |
7 |
|
Futures contracts – copper and aluminum |
|
Costs of products sold (excluding depreciation and amortization) |
|
|
114 |
|
|
|
(126 |
) |
|
|
202 |
|
12. |
Fair Value |
The Corporation’s financial assets and liabilities that are reported at fair value in the condensed consolidated balance sheets as of March 31, 2019, and December 31, 2018, were as follows:
|
|
Quoted Prices in Active Markets for Identical Inputs (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Total |
|
||||
As of March 31, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other noncurrent assets |
|
$ |
3,973 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
3,973 |
|
Foreign currency exchange contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other current assets |
|
|
0 |
|
|
|
552 |
|
|
|
0 |
|
|
|
552 |
|
Other noncurrent assets |
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
Other current liabilities |
|
|
0 |
|
|
|
1,021 |
|
|
|
0 |
|
|
|
1,021 |
|
Other noncurrent liabilities |
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
As of December 31, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other noncurrent assets |
|
$ |
3,659 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
$ |
3,659 |
|
Foreign currency exchange contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other current assets |
|
|
0 |
|
|
|
1,011 |
|
|
|
0 |
|
|
|
1,011 |
|
Other noncurrent assets |
|
|
0 |
|
|
|
105 |
|
|
|
0 |
|
|
|
105 |
|
Other current liabilities |
|
|
0 |
|
|
|
962 |
|
|
|
0 |
|
|
|
962 |
|
Other noncurrent liabilities |
|
|
0 |
|
|
|
70 |
|
|
|
0 |
|
|
|
70 |
|
15
The investments held as other noncurrent assets represent assets held in a “Rabbi” trust for the purpose of providing benefits under a non-qualified defined benefit pension plan. The fair value of the investments is based on quoted prices of the investments in active markets. The fair value of foreign currency exchange contracts is determined based on the fair value of similar contracts with similar terms and remaining maturities. The fair value of futures contracts is based on market quotations. The fair value of the variable-rate IRB debt and borrowings under the Credit Agreement approximate their carrying value. Additionally, the fair value of trade receivables and trade payables approximates their carrying value.
13. |
Revenue |
Net sales and (loss) income from continuing operations before income taxes by geographic area for the three months ended March 31, 2019, and 2018, are as outlined below. When disaggregating revenue, consideration is given to information regularly reviewed by the chief operating decision maker to evaluate the financial performance of the operating segments and make resource allocation decisions. (Loss) income from continuing operations before income taxes for the three months ended March 31, 2019, includes an impairment charge of $10,082 for the write-down of certain assets of the Corporation’s cast roll manufacturing facility in Avonmore, Pennsylvania to their net realizable value. See Note 18.
|
|
|
|
|
|
|
||||||||||
|
|
Net Sales |
|
|
(Loss) Income from Continuing Operations Before Income Taxes |
|
||||||||||
|
|
Three Months Ended March 31, |
|
|
Three Months Ended March 31, |
|
||||||||||
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
||||
United States |
|
$ |
51,481 |
|
|
$ |
53,436 |
|
|
$ |
(13,309 |
) |
|
$ |
(2,175 |
) |
Foreign |
|
|
56,013 |
|
|
|
52,979 |
|
|
|
1,401 |
|
|
|
3,170 |
|
|
|
$ |
107,494 |
|
|
$ |
106,415 |
|
|
$ |
(11,908 |
) |
|
$ |
995 |
|
Substantially all of the foreign net sales for each of the periods are attributable to the Forged and Cast Engineered Products segment. Net sales by product line for the three months ended March 31, 2019, and 2018, were as follows:
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Forged and cast mill rolls |
|
$ |
77,286 |
|
|
$ |
67,488 |
|
Forged engineered products |
|
|
8,004 |
|
|
|
17,758 |
|
Heat exchange coils |
|
|
6,299 |
|
|
|
6,401 |
|
Centrifugal pumps |
|
|
8,633 |
|
|
|
8,375 |
|
Air handling systems |
|
|
7,272 |
|
|
|
6,393 |
|
|
|
$ |
107,494 |
|
|
$ |
106,415 |
|
14. |
Stock-Based Compensation |
The Ampco-Pittsburgh Corporation 2016 Omnibus Incentive Plan (the “Incentive Plan”) authorizes the issuance of up to 1,100,000 shares of the Corporation’s common stock for awards under the Incentive Plan. Awards under the Incentive Plan may include incentive non-qualified stock options, stock appreciation rights, restricted shares and restricted stock units, performance awards, other stock-based awards or short-term cash incentive awards. If any award is canceled, terminates, expires or lapses for any reason prior to the issuance of shares, or if shares are issued under the Incentive Plan and thereafter are forfeited to the Corporation, the shares subject to such awards and the forfeited shares will not count against the aggregate number of shares available under the Incentive Plan. Shares tendered or withheld to pay the option exercise price or tax withholding will continue to count against the aggregate number of shares of common stock available for grant under the Incentive Plan. Any shares repurchased by the Corporation with cash proceeds from the exercise of options will not be added back to the pool of shares available for grant under the Incentive Plan.
The Incentive Plan may be administered by the Board of Directors or the Compensation Committee of the Board of Directors. The Compensation Committee has the authority to determine, within the limits of the express provisions of the Incentive Plan, the individuals to whom the awards will be granted and the nature, amount and terms of such awards.
The Incentive Plan also provides for equity-based awards during any one year to non-employee members of the Board of Directors, based on the grant date fair value, not to exceed $200. The limit does not apply to shares received by a non-employee director at his or her election in lieu of all or a portion of the director’s retainer for board service.
Stock-based compensation expense for the three months ended March 31, 2019, and 2018, equaled $305 and $666, respectively. There was no income tax benefit for either of the periods due to the Corporation having a valuation allowance recorded against its deferred income tax assets for the jurisdiction where the expense is recognized.
16
The Corporation and its subsidiaries are involved in various claims and lawsuits incidental to their businesses and are also subject to asbestos litigation as described below. In February 2017, the Corporation, its indirect subsidiary Akers National Roll Company, as well as the Akers National Roll Company Health & Welfare Benefits Plan were named as defendants in a class action complaint filed in the United States District Court for the Western District of Pennsylvania, where the plaintiffs (currently retired former employees of Akers National Roll Company and the United Steel, Paper and Forestry, Rubber, Manufacturing, Energy, Allied Industrial, and Service Workers International Union, AFL-CIO) alleged that the defendants breached collective bargaining agreements and violated the benefit plan by modifying medical benefits of the plaintiffs and similarly situated retirees. The defendants moved to dismiss the case, and plaintiffs petitioned the court to compel arbitration. On June 13, 2017, the District Court compelled arbitration and denied the defendants’ motion to dismiss as moot. Defendants appealed this decision to the Third Circuit Court of Appeals on June 21, 2017. The Third Circuit Court of Appeals reversed the District Court’s decision to compel arbitration on August 29, 2018. The plaintiffs filed a petition for rehearing, which was denied. Rather than litigating the merits of the case at the United States District Court for the Western District of Pennsylvania, the Corporation reached a settlement agreement in principle with the plaintiffs, which has been preliminarily approved by the court but remains subject to the court’s final approval subsequent to a hearing to be held on July 22, 2019. As expected, the final resolution of this settlement agreement will not have a material adverse effect on our results of operations, financial position, liquidity or capital resources.
Asbestos Litigation
Claims have been asserted alleging personal injury from exposure to asbestos-containing components historically used in some products manufactured by predecessors of Air & Liquid (“Asbestos Liability”). Air & Liquid, and in some cases the Corporation, are defendants (among a number of defendants, often in excess of 50) in cases filed in various state and federal courts.
Asbestos Claims
The following table reflects approximate information about the claims for Asbestos Liability against Air & Liquid and the Corporation for the three months ended March 31, 2019, and 2018 (claims not in thousands):
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Total claims pending at the beginning of the period |
|
|
6,772 |
|
|
|
6,907 |
|
New claims served |
|
|
333 |
|
|
|
287 |
|
Claims dismissed |
|
|
(90 |
) |
|
|
(112 |
) |
Claims settled |
|
|
(56 |
) |
|
|
(78 |
) |
Total claims pending at the end of the period (1) |
|
|
6,959 |
|
|
|
7,004 |
|
Gross settlement and defense costs (in 000’s) |
|
$ |
2,789 |
|
|
$ |
6,881 |
|
Avg. gross settlement and defense costs per claim resolved (in 000’s) |
|
$ |
19.10 |
|
|
$ |
36.22 |
|
|
(1) |
Included as “open claims” are approximately 666 and 479 claims in 2019 and 2018, respectively, classified in various jurisdictions as “inactive” or transferred to a state or federal judicial panel on multi-district litigation, commonly referred to as the MDL. |
A substantial majority of the settlement and defense costs reflected in the above table was reported and paid by insurers. Because claims are often filed and can be settled or dismissed in large groups, the amount and timing of settlements, as well as the number of open claims, can fluctuate significantly from period to period.
Asbestos Insurance
The Corporation and Air & Liquid are parties to a series of settlement agreements (“Settlement Agreements”) with insurers that have coverage obligations for Asbestos Liability (the “Settling Insurers”). Under the Settlement Agreements, the Settling Insurers accept financial responsibility, subject to the terms and conditions of the respective agreements, including overall coverage limits, for pending and future claims for Asbestos Liability. The Settlement Agreements encompass the substantial majority of insurance policies that provide coverage for claims for Asbestos Liability.
The Settlement Agreements include acknowledgements that Howden North America, Inc. (“Howden”) is entitled to coverage under policies covering Asbestos Liability for claims arising out of the historical products manufactured or distributed by Buffalo Forge, a former subsidiary of the Corporation (the “Products”), which was acquired by Howden. The Settlement Agreements do not provide for any prioritization on access to the applicable policies or any sublimits of liability as to Howden or the Corporation and Air & Liquid, and, accordingly, Howden may access the coverage afforded by the Settling Insurers for any covered claim arising out of a Product. In general, access by Howden to the coverage afforded by the Settling Insurers for the
17
Products will erode coverage under the Settlement Agreements available to the Corporation and Air & Liquid for Asbestos Liability.
Asbestos Valuations
In 2006, the Corporation retained Hamilton, Rabinovitz & Associates, Inc. (“HR&A”), a nationally recognized expert in the valuation of asbestos liabilities, to assist the Corporation in estimating the potential liability for pending and unasserted future claims for Asbestos Liability. Based on this analysis, the Corporation recorded a reserve for Asbestos Liability claims pending or projected to be asserted through 2013 as of December 31, 2006. HR&A’s analysis has been periodically updated since that time. In 2018, the Corporation engaged Nathan Associates Inc. (“Nathan”) to update the liability valuation, and additional reserves were established by the Corporation as of December 31, 2018, for Asbestos Liability claims pending or projected to be asserted through 2052. The methodology used by Nathan in its projection in 2018 of the operating subsidiaries’ liability for pending and unasserted potential future claims for Asbestos Liability, which is substantially the same as the methodology employed by HR&A in prior estimates, relied upon and included the following factors:
|
• |
interpretation of a widely accepted forecast of the population likely to have been exposed to asbestos; |
|
• |
epidemiological studies estimating the number of people likely to develop asbestos-related diseases; |
|
• |
analysis of the number of people likely to file an asbestos-related injury claim against the subsidiaries and the Corporation based on such epidemiological data and relevant claims history from January 1, 2016, to August 19, 2018; |
|
• |
an analysis of pending cases, by type of injury claimed and jurisdiction where the claim is filed; |
|
• |
an analysis of claims resolution history from January 1, 2016, to August 19, 2018, to determine the average settlement value of claims, by type of injury claimed and jurisdiction of filing; and |
|
• |
an adjustment for inflation in the future average settlement value of claims, at an annual inflation rate based on the Congressional Budget Office’s ten year forecast of inflation. |
Using this information, Nathan estimated in 2018 the number of future claims for Asbestos Liability that would be filed through the year 2052, as well as the settlement or indemnity costs that would be incurred to resolve both pending and future unasserted claims through 2052. This methodology has been accepted by numerous courts.
In conjunction with developing the aggregate liability estimate referenced above, the Corporation also developed an estimate of probable insurance recoveries for its Asbestos Liability. In developing the estimate, the Corporation considered Nathan’s projection for settlement or indemnity costs for Asbestos Liability and management’s projection of associated defense costs (based on the current defense to indemnity cost ratio), as well as a number of additional factors. These additional factors included the Settlement Agreements in effect, policy exclusions, policy limits, policy provisions regarding coverage for defense costs, attachment points, prior impairment of policies and gaps in the coverage, policy exhaustions, insolvencies among certain of the insurance carriers, and the nature of the underlying claims for Asbestos Liability asserted against the subsidiaries and the Corporation as reflected in the Corporation’s asbestos claims database, as well as estimated erosion of insurance limits on account of claims against Howden arising out of the Products. In addition to consulting with the Corporation’s outside legal counsel on these insurance matters, the Corporation consulted with a nationally recognized insurance consulting firm it retained to assist the Corporation with certain policy allocation matters that also are among the several factors considered by the Corporation when analyzing potential recoveries from relevant historical insurance for Asbestos Liability. Based upon all of the factors considered by the Corporation, and taking into account the Corporation’s analysis of publicly available information regarding the credit-worthiness of various insurers, the Corporation estimated the probable insurance recoveries for Asbestos Liability and defense costs through 2052.
With the assistance of Nathan, the Corporation extended its estimate of the Asbestos Liability, including the costs of settlement and defense costs relating to currently pending claims and future claims projected to be filed against the Corporation through the estimated final date by which the Corporation expects to have settled all asbestos-related claims in 2052. The Corporation’s previous estimate was for asbestos claims filed or projected to be filed against the Corporation through 2026. Our ability to reasonably estimate this liability through the expected final date of settlement for all asbestos-related claims of this litigation instead of a ten-year period was based on several factors:
|
• |
There have been generally favorable trends developments in the trend of case law which has been a contributing factor in stabilizing the asbestos claims activity and related settlement and defense costs; |
|
• |
There have been significant actions taken by certain state legislatures and courts that have reduced the number and type of claims that can proceed to trial; |
|
• |
The Corporation has coverage-in-place agreements with almost all of its excess insurers which enables the Corporation to project a stable relationship between settlement and defense costs paid by the Corporation and reimbursements from its insurers; and |
18
|
• |
Annual settlements with respect to groups of cases with certain plaintiff firms have helped to stabilize indemnity payments and defense costs. |
Taking these factors into consideration, the Corporation believes there is greater predictability of outcomes from settlements, a reduction in the volatility of defense costs, and it has gained substantial experience as an asbestos defendant. As a result, the Corporation believes the uncertainty in estimating the Asbestos Liability beyond 10 years has been reduced and it now has sufficient information to estimate the Asbestos Liability through 2052, the estimated final date by which the Corporation expects to have settled all asbestos-related claims.
The Corporation’s reserve at December 31, 2018, for the total costs, including defense costs, for Asbestos Liability claims pending or projected to be asserted through 2052, was $227,922. The reserve at March 31, 2019, was $225,133. Defense costs are estimated at 80% of settlement costs. The Corporation’s receivable at December 31, 2018, for insurance recoveries attributable to the claims for which the Corporation’s Asbestos Liability reserve has been established, including the portion of incurred defense costs covered by the Settlement Agreements in effect through December 31, 2018, and the probable payments and reimbursements relating to the estimated indemnity and defense costs for pending and unasserted future Asbestos Liability claims, was $152,508 ($150,093 at March 31, 2019).
The following table summarizes activity relating to insurance recoveries for each of the three months ended March 31, 2019, and 2018.
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Insurance receivable – asbestos, beginning of the year |
|
$ |
152,508 |
|
|
$ |
100,342 |
|
Settlement and defense costs paid by insurance carriers |
|
|
(2,415 |
) |
|
|
(4,954 |
) |
Insurance receivable – asbestos, end of the period |
|
$ |
150,093 |
|
|
$ |
95,388 |
|
The insurance receivable recorded by the Corporation does not assume any recovery from insolvent carriers and a substantial majority of the insurance recoveries deemed probable is from insurance companies rated A – (excellent) or better by A.M. Best Corporation. There can be no assurance, however, that there will not be further insolvencies among the relevant insurance carriers, or that the assumed percentage recoveries for certain carriers will prove correct. The difference between insurance recoveries and projected costs is not due to exhaustion of all insurance coverage for Asbestos Liability.
The amounts recorded by the Corporation for Asbestos Liability and insurance receivable rely on assumptions that are based on currently known facts and strategy. The Corporation’s actual expenses or insurance recoveries could be significantly higher or lower than those recorded if assumptions used in the Corporation’s or Nathan’s calculations vary significantly from actual results. Key variables in these assumptions are identified above and include the number and type of new claims to be filed each year, the average cost of disposing of each such new claim, average annual defense costs, compliance by relevant parties with the terms of the Settlement Agreements, and the solvency risk with respect to the relevant insurance carriers. Other factors that may affect the Corporation’s Asbestos Liability and ability to recover under its insurance policies include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, reforms that may be made by state and federal courts, and the passage of state or federal tort reform legislation.
The Corporation intends to evaluate its estimated Asbestos Liability and related insurance receivable as well as the underlying assumptions on a regular basis to determine whether any adjustments to the estimates are required. Due to the uncertainties surrounding asbestos litigation and insurance, these regular reviews may result in the Corporation incurring future charges; however, the Corporation is currently unable to estimate such future charges. Adjustments, if any, to the Corporation’s estimate of its recorded Asbestos Liability and/or insurance receivable could be material to operating results for the periods in which the adjustments to the liability or receivable are recorded, and to the Corporation’s liquidity and consolidated financial position.
16. |
Environmental Matters |
The Corporation is currently performing certain remedial actions in connection with the sale of real estate previously owned and periodically incurs costs to maintain compliance with environmental laws and regulations. Environmental exposures are difficult to assess and estimate for numerous reasons, including lack of reliable data, the multiplicity of possible solutions, the years of remedial and monitoring activity required, and identification of new sites. In the opinion of management, the potential liability for environmental compliance measures of approximately $328 at March 31, 2019, is considered adequate based on information known to date.
19
Presented below are the net sales and (loss) income from continuing operations before income taxes for the Corporation’s two business segments. For the three months ended March 31, 2019, the operating loss of the Forged and Cast Engineered Products segment includes an impairment charge of $10,082 associated with the anticipated sale of certain assets of Akers National Roll Company. For the three months ended March 31, 2018, other expense, including corporate costs, includes the impact of a favorable contractual settlement with a third party of approximately $2,425.
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Net sales: |
|
|
|
|
|
|
|
|
Forged and Cast Engineered Products |
|
$ |
85,290 |
|
|
$ |
85,246 |
|
Air and Liquid Processing |
|
|
22,204 |
|
|
|
21,169 |
|
Total Reportable Segments |
|
$ |
107,494 |
|
|
$ |
106,415 |
|
(Loss) income from continuing operations before income taxes: |
|
|
|
|
|
|
|
|
Forged and Cast Engineered Products |
|
$ |
(10,033 |
) |
|
$ |
202 |
|
Air and Liquid Processing |
|
|
2,143 |
|
|
|
2,259 |
|
Total Reportable Segments |
|
|
(7,890 |
) |
|
|
2,461 |
|
Other expense, including corporate costs |
|
|
(4,018 |
) |
|
|
(1,466 |
) |
Total |
|
$ |
(11,908 |
) |
|
$ |
995 |
|
18. Subsequent Events
On May 6, 2019, Akers National Roll Company, a subsidiary of the Corporation, entered into a definitive agreement to sell certain assets, including real estate and personal property, of its Avonmore, Pennsylvania, cast roll manufacturing facility to an affiliate of WHEMCO, Inc. It is expected the transaction will close in the second half of 2019, following cessation of roll finishing operations once remaining customer commitments are fulfilled.
On May 9, 2019, the shareholders of the Corporation approved an amendment to the Corporation’s Amended and Restated Articles of Incorporation to increase the number of authorized shares of the Corporation’s common stock from 20,000,000 shares to 40,000,000 shares.
20
ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(in thousands, except share and per share amounts)
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on the Corporation’s behalf. Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of the Form 10-Q, as well as the condensed consolidated financial statements and notes thereto, may include, but are not limited to, statements about operating performance, trends, events that we expect or anticipate will occur in the future, statements about sales levels, divestitures, restructuring, the effect of any impairment charges, profitability and anticipated expenses and cash outflows. All statements in this document other than statements of historical fact are statements that are, or could be, deemed “forward-looking statements” within the meaning of the Act and words such as “may,” “intend,” “believe,” “expect,” “anticipate,” “estimate,” “project,” “forecast” and other terms of similar meaning that indicate future events and trends are also generally intended to identify forward-looking statements. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations, and involve risks and uncertainties. For the Corporation, these risks and uncertainties include, but are not limited to: cyclical demand for products and economic downturns; excess global capacity in the steel industry; increases in commodity prices or shortages of key production materials; a work stoppage or similar industrial action; currency fluctuations; inability of the Corporation to successfully consummate proposed divestitures or restructure its operations; limitations in availability of capital to fund our strategic plan; and those discussed more fully elsewhere in this report and in documents filed with the Securities and Exchange Commission by the Corporation, particularly in Item 1A, Risk Factors, in Part I of the Corporation’s latest annual report on Form 10-K for the year ended December 31, 2018, and subsequent filings. The Corporation cannot guarantee any future results, levels of activity, performance or achievements. In addition, there may be events in the future that the Corporation may not be able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, we assume no obligation, and disclaim any obligation, to update forward-looking statements whether as a result of new information, events or otherwise.
Executive Overview
Ampco-Pittsburgh Corporation and its subsidiaries (the “Corporation”) manufacture and sell highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. We operate in two business segments – the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment.
Forged and Cast Engineered Products
The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, open-die forged products, and specialty steel ingot and cast billet products. Forged hardened steel rolls are used mainly for rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot and cold strip mills, medium/heavy section mills and plate mills. Ingot and forged engineered products are used in the oil and gas industry and the aluminum and plastic extrusion industries. Specialty steel ingot and cast billet products are used primarily by the open-die industry and downstream rolled-steel producers. The segment has operations in the United States, England, Sweden, Slovenia, Canada and an equity interest in three joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.
Roll market conditions in the United States and Europe continue to benefit from the trade protectionist acts. However, tariffs on U.S imports of primary steel products from Canada have adversely impacted our Canadian operations and the cost structure of our forged engineered products. With respect to the oil and gas market, the slowdown in the second half of 2018 continued through the first quarter of 2019.
In October 2018, the Board of Directors of the Corporation approved a plan to sell ASW Steel Inc. (“ASW”). ASW is our specialty steel producer based in Canada which we acquired in November 2016. Loss of significant U.S. business due to a combination of tariffs imposed by the United States on imports of primary steel and loss of a key customer as a result of a plant closure have resulted in significant losses for the Canadian operation. While we will continue to service the open-die forged products market, we will not have a dedicated supply of required specialty steel through a back-end integration of ASW. We expect to enter into a long-term supply agreement post-sale for the supply of steel ingots. Also, we will no longer manufacture and supply primary specialty steels to customers in the non-roll opened and closed die forgings and rebar markets and will exit the Canadian market. Collectively, the sale of ASW represents a strategic shift that will have a major impact on our results of operations and has been accounted for as a discontinued operation.
In March 2019, the Board of Directors of the Corporation approved a plan to sell a cast roll manufacturing facility located in Avonmore, PA (the “Avonmore Plant”), owned by the Corporation’s subsidiary, Akers National Roll Company (“ANR”). On May 6, 2019, ANR entered into a definitive agreement to sell the Avonmore Plant, including real estate and personal property related thereto,
21
to an affiliate of WHEMCO, Inc. Excess capacity and high operating costs in our cast roll system have made operation of the Avonmore Plant unsustainable. It is expected the transaction will close in the second half of 2019, once remaining customer orders are completed. In connection with the anticipated sale, we recorded an impairment charge of $10,082 in the first quarter of 2019, to record the assets at their estimated net realizable value. See Note 2 to the Condensed Consolidated Financial Statements.
The Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid Systems Corporation (“Air & Liquid”), a wholly owned subsidiary of the Corporation. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including OEM/commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment distributes a significant portion of its products through a common independent group of sales offices located throughout the United States and Canada.
For the Air and Liquid Processing segment, business activity in the specialty centrifugal pump industry has been negatively impacted by a decline in activity in the fossil-fueled power generation market, partially offset by increased activity in the marine defense market. For the heat exchanger business, there are early signs of growth in the industrial market. Additionally, demand for custom air handling systems remains steady although competitive pricing pressures continue. The focus for this segment is to grow revenues, increase margins, strengthen engineering and manufacturing capabilities, and continue to improve the sales distribution network.
Consolidated Results from Continuing Operations for the Three Months Ended March 31, 2019 and 2018
Net sales were $107,494, and $106,415, for the three months ended March 31, 2019, and 2018, respectively. Backlog approximated $349,386 at March 31, 2019, versus $343,079 as of December 31, 2018, and $345,816 at March 31, 2018. A discussion of sales and backlog for our two segments is included below.
Costs of products sold, excluding depreciation and amortization, as a percentage of net sales was higher for the three months ended March 31, 2019, when compared to the three months ended March 31, 2018. The increase is primarily due to lower production volumes for forged engineered products, particularly to the oil and gas industry, and product mix for our cast roll operations. Improved pricing helped to offset the impact.
Selling and administrative expenses decreased for the three months ended March 31, 2019, when compared to the three months ended March 31, 2018. The current period includes higher professional fees associated with our overall corporate restructuring plan; however, the impact was more than offset by lower employee-related costs, commissions, and research and development expense.
Impairment charge represents the write down of certain assets of our Avonmore facility to their estimated net realizable value (the “Impairment Charge”).
Loss from continuing operations for the three months ended March 31, 2019, approximated $11,959 and includes the Impairment Charge of $10,082 and professional fees associated with our overall corporate restructuring plan and employee severance costs due to a reduction in force (the “Restructuring-Related Costs”) undertaken and completed in the first quarter of 2019 of $921. By comparison, loss from continuing operations for the three months ended March 31, 2018, approximated $1,777.
Net sales and operating results by segment
Forged and Cast Engineered Products. Sales for the Forged and Cast Engineered Products segment for the three months ended March 31, 2019, and 2018, were comparable. While shipments of forged and cast rolls improved, sales of forged engineered products decreased. Specifically, sales of frac blocs to the oil and gas industry decreased from a year ago as the market decline in the second half of 2018 continued through the first quarter of 2019. Operating results for the three months ended March 31, 2019, decreased by $10,235 from a year ago, and includes the Impairment Charge of $10,082. Backlog approximated $295,724 at March 31, 2019, compared to $298,723 at December 31, 2018, and $299,505 at March 31, 2018. Quarter-end backlog for mill rolls was comparable to backlog at December 31, 2018, and approximately 5% higher than a year ago due to improved demand and pricing. By comparison, backlog for forged engineered products was less at March 31, 2019, when compared to each of the earlier periods, as a result of the ongoing softening in the oil and gas industry. Approximately $68,790 of the current backlog is expected to ship after 2019.
Air and Liquid Processing. Net sales for the three months ended March 31, 2019, increased when compared to the same period of the prior year. Sales of air handling units benefitted from a higher opening backlog resulting from improved demand while sales of centrifugal pumps improved due to a higher volume of shipments to U.S. Navy shipbuilders. Sales of heat exchange coils continue to be adversely impacted by a lower volume of shipments to the nuclear and fossil-fueled power generation market. Operating income for the quarter decreased by approximately 5% from the prior year primarily due to product mix. At March 31, 2019, backlog
22
approximated $53,662 which compares to $44,356 at December 31, 2018, and $46,311 at March 31, 2018. The increase in backlog over the prior periods is primarily attributable to orders for U.S. Navy shipbuilders. The majority of the current backlog is expected to ship in 2019.
Interest expense for the current year period increased over the comparable prior year period principally due to interest on the sale and leaseback financing transaction completed in September 2018, offset by lower interest on promissory notes which were repaid on March 4, 2019.
Other income (expense) net decreased for the three months ended March 31, 2019, when compared to the same period of the prior year. The decrease is principally due to a favorable contract settlement with a third party in the first quarter of 2018 of $2,425.
Income tax (provision) benefit for each of the periods includes income taxes associated with our profitable operations. An income tax benefit is not able to be recognized on losses of certain of our entities since they remain in a three-year cumulative loss position. Additionally, the income tax provision for the three months ended March 31, 2018, includes: (i) a $1,242 benefit from the release of a valuation allowance previously established against the deferred income tax assets of one of our foreign subsidiaries on the basis that it was “more likely than not” the deferred income tax assets would be realized, (ii) a benefit for the carryback of additional 2017 tax losses of $986, and (iii) a refund of AMT credits of $489. The additional benefit was partially offset by recognition of a one-time tax on the deemed repatriation of previously untaxed foreign earnings of approximately $2,135.
Net (loss) income from continuing operations and (loss) income per common share for the three months ended March 31, 2019, and 2018, equaled $(12,551), or $(1.00) per common share, and $1,458, or $0.12 per common share, respectively. The Impairment Charge recorded in the first quarter of 2019, adversely impacted net (loss) from continuing operations by $10,082, or $0.81 per common share.
Non-GAAP Financial Measure
As indicated, in March 2019, the Board of Directors of the Corporation approved a plan to sell the Avonmore Plant owned by ANR. In connection with the anticipated disposal, we recognized the Impairment Charge of $10,082 to record the assets to their estimated net realizable value. We also recorded the Restructuring-Related Costs of $921 during the quarter, which consisted of professional fees associated with our overall corporate restructuring plan and employee severance costs associated with a reduction in force undertaken and completed in the first quarter of 2019.
We present below non-GAAP adjusted income from continuing operations, which we calculate as our loss from continuing operations, excluding the Impairment Charge, the Restructuring-Related Costs and estimated excess costs associated with ANR. This non-GAAP financial measure is not based on any standardized methodology prescribed by accounting principles generally accepted in the United States of America (“GAAP”) and is not comparable to similarly-titled measures presented by other companies.
We have presented adjusted income from continuing operations because it is a key measure used by our management and Board of Directors to understand and evaluate our operating performance and to develop operational goals for managing our business. This non-GAAP financial measure excludes significant charges, or credits, that are one-time charges or credits, unrelated to our ongoing results of operations or are beyond our control. Additionally, a portion of the incentive and compensation arrangements for certain employees is based on the Corporation’s business performance. We believe this non-GAAP financial measure helps identify underlying trends in our business that could otherwise be masked by the effect of the items that we exclude. In particular, we believe that the exclusion of the Impairment Charge, the Restructuring-Related Costs and the estimated excess costs of ANR, which are not expected to continue following the sale of the Avonmore Plant, can provide a useful measure for period-to-period comparisons of our core business performance. Accordingly, we believe that this non-GAAP financial measure provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects and allowing for greater transparency with respect to key financial metrics used by our management in its financial and operational decision-making.
Adjusted income from continuing operations is not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are limitations related to the use of adjusted income from continuing operations rather than loss from continuing operations which is the nearest GAAP equivalent. Among other things, estimated excess costs of ANR, which is excluded from the adjusted non-GAAP financial measure, necessarily reflect judgments made by management in allocating manufacturing and operating costs between the Avonmore Plant and the Corporation’s other operations and in anticipating how it will conduct business following the sale of the Avonmore Plant. Estimated excess costs of ANR will continue until the Avonmore Plant is sold and additional costs could be incurred in conjunction with the sale. Also, there can be no assurance that additional charges similar to the Impairment Charge and the Restructuring-Related Costs will not occur in future periods.
23
The adjustments reflected in adjusted income from continuing operations are pre-tax. There is no tax benefit associated with these adjustments due to our having a valuation allowance recorded against our deferred income tax assets for the jurisdictions where the expenses are recognized.
The following is a reconciliation of loss from continuing operations to non-GAAP adjusted income from continuing operations for the three-month periods ended March 31, 2019, and 2018, respectively:
|
|
(Loss) from Continuing Operations |
|
|||||
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Loss from continuing operations, as reported (GAAP) |
|
$ |
(11,959 |
) |
|
$ |
(1,777 |
) |
Impairment Charge (1) |
|
|
10,082 |
|
|
|
0 |
|
Restructuring-Related Costs (2) |
|
|
921 |
|
|
|
0 |
|
Estimated excess costs of ANR (3) |
|
|
2,202 |
|
|
|
2,308 |
|
Income from continuing operations as adjusted (Non-GAAP) |
|
$ |
1,246 |
|
|
$ |
531 |
|
(1) |
Represents an impairment charge to record certain assets of ANR to their estimated net realizable value in connection with their anticipated sale. |
(2) |
Represents professional fees associated with the Corporation’s overall restructuring plan and employee severance costs due to a reduction in force. |
(3) |
Represents estimated net operating costs of ANR which are not expected to continue after the sale of the Avonmore Plant. The estimated excess costs include judgments made by management in allocating manufacturing and operating costs between the Avonmore Plant and the Corporation’s other operations and in anticipating how it will conduct business following the sale of the Avonmore Plant. Estimated excess costs of ANR will continue until the Avonmore Plant is sold and additional costs could be incurred in conjunction with the sale. |
Results from Discontinued Operations for the Three Months Ended March 31, 2019 and 2018
Net loss from discontinued operations, net of tax, and loss from discontinued operations per common share for the three months ended March 31, 2019, and 2018, equaled $(2,242), or $(0.18) per common share, and $(69), or $(0.01) per common share, respectively. The loss is associated with ASW, which is held for sale. The higher loss from a year ago is attributable to a lower volume of shipments to the U.S. due to tariffs imposed by the U.S. on imports of primary steel, lower demand of ingot feedstock for the production of forged engineered products for the oil and gas industry, and changes in product mix.
Liquidity and Capital Resources
Net cash flows used in operating activities for continuing operations for the three months ended March 31, 2019, improved slightly when compared to the three months ended March 31, 2018. Although we recorded an impairment charge associated with the anticipated sale of certain of the assets of our Avonmore cast roll facility, the charge was a non-cash charge and, accordingly, did not impact our net cash flows used in operating activities. The increase in accounts receivable from December 31, 2018, to March 31, 2019, is attributable to higher first quarter 2019 sales when compared to fourth quarter of 2018, and the increase in accounts payable from December 31, 2018, to March 31, 2019, is a result of our ongoing effort to achieve a better balance and duration of trade receivables and trade payables as part of our overall working capital management effort.
Net cash flows used in investing activities for continuing operations were comparable for the three months ended March 31, 2019, and 2018. As of March 31, 2019, commitments for future capital expenditures approximated $1,600 which is expected to be spent over the next 12 months.
Net cash flows (used in) provided by financing activities for continuing operations fluctuated as a result of borrowing activity. In 2019, we borrowed from our revolving credit facility to repay promissory notes (and interest) that were issued in connection with a 2016 acquisition. By comparison, borrowings from the revolving credit facility in 2018 were reinvested in our businesses.
As a result of the above, cash and cash equivalents decreased by $9,270 in 2019, and ended the period at $10,443 in comparison to $19,713 at December 31, 2018. As of March 31, 2019, the majority of our cash and cash equivalents are held by our foreign operations. In an effort to minimize borrowings under our revolving credit facility, we have instituted a springing lock-box feature whereby domestic customer remittances to the lock-box are used to pay down borrowings under our revolving credit facility. Accordingly, minimal cash is maintained by our domestic operations.
Cash held by our foreign operations is considered to be permanently reinvested; accordingly, a provision for estimated local and withholding tax has not been made. If we were to remit any foreign earnings to the U.S., the estimated tax impact would be insignificant.
Funds on hand, funds generated from future operations and availability under our revolving credit facility are expected to be sufficient to finance our operational and capital expenditure requirements. As of March 31, 2019, remaining availability under the revolving credit facility approximated $39,000, net of standard availability reserves. While the revolving credit agreement limits the amount of
24
distributions upstream, we have not historically relied on or have been dependent on distributions from our subsidiaries and are not expected to be in the future.
Litigation and Environmental Matters
See Notes 15 and 16 to the condensed consolidated financial statements.
Critical Accounting Pronouncements
The Corporation’s critical accounting policies, as summarized in its Annual Report on Form 10-K for the year ended December 31, 2018, remain unchanged.
Recently Issued Accounting Pronouncements
See Note 1 to the condensed consolidated financial statements.
ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable.
ITEM 4 – CONTROLS AND PROCEDURES
(a) |
Disclosure controls and procedures. An evaluation of the effectiveness of the Corporation’s disclosure controls and procedures as of the end of the period covered by this report was carried out under the supervision, and with the participation, of management, including the principal executive officer and principal financial officer. Disclosure controls and procedures are defined under Securities and Exchange Commission (“SEC”) rules as controls and other procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported within the required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Corporation’s management, including the principal executive officer and principal financial officer, has concluded that the Corporation’s disclosure controls and procedures were effective as of March 31, 2019. |
(c) |
Changes in Internal Control. There has been no change in the Corporation’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Securities Exchange Act of 1934 that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. |
25
AMPCO-PITTSBURGH CORPORATION
The information contained in Note 15 to the condensed consolidated financial statements (Litigation) is incorporated herein by reference.
There are no material changes to the Risk Factors contained in Item 1A to Part I of the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2018.
Items 2-5 |
None |
|
|
|
||||
(3.1) |
|
|||||
|
|
|
||||
(31.1) |
|
|||||
|
|
|
||||
(31.2) |
|
|||||
|
|
|||||
(32.1) |
|
|||||
|
|
|
||||
(32.2) |
|
|||||
|
|
|
||||
(101) |
|
Interactive Data File (XBRL) |
26
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
AMPCO-PITTSBURGH CORPORATION |
||
|
|
|
|
|
DATE: May 10, 2019 |
|
BY: |
|
/s/ J. Brett McBrayer |
|
|
|
|
J. Brett McBrayer |
|
|
|
|
Director and Chief Executive Officer |
|
|
|
|
|
DATE: May 10, 2019 |
|
BY: |
|
/s/ Michael G. McAuley |
|
|
|
|
Michael G. McAuley |
|
|
|
|
Senior Vice President, Chief Financial Officer and Treasurer |
27